Much of life went virtual during the COVID-19 pandemic — work, school and even some doctor's appointments. So did many support groups for people with alcohol use disorder. But people who attended ...

During cognitive behavioral therapy (CBT) for alcohol use disorder (AUD), a person may discuss factors that contribute to their condition and learn alternative coping mechanisms. AUD is a form of ...

Participants in an IFS PTSD-SUD (substance use disorder) intervention experienced reduced PTSD symptoms and cravings, making it a promising public health treatment option.

Alcohol Use Disorder (AUD) is a chronic relapsing brain disease characterized by compulsive alcohol use, loss of control over alcohol intake, and a negative emotional state when not using. You may ...

Evidence is mounting that new therapies already used to treat gut diseases, type 2 diabetes, and obesity may help people with alcohol use disorder (AUD). Glucagon-like peptide 1 (GLP-1) receptor ...

Many people don’t realize they have an alcohol problem. Yet early indicators of alcohol issues show that if attention were paid, excessive drinking might be headed off before alcoholism develops. For ...

PHILADELPHIA — Patients with alcohol-associated liver disease (ALD) could benefit from treatment of alcohol use disorder (AUD), yet pharmacologic therapy remains underutilized in this at-risk group, ...

Starting oral or injectable naltrexone at hospital discharge reduced heavy drinking in patients with alcohol use disorder. The hospital is an opportune setting for identifying and treating patients ...

Baclofen, a GABA B receptor agonist traditionally used as a muscle relaxant, has emerged as a promising pharmacological option in the management of Alcohol Use Disorder (AUD). By modulating inhibitory ...

Please provide your email address to receive an email when new articles are posted on . Postdischarge pharmacotherapy rates rose from 12.6% in 2014 to 23.9% in 2023 for ALD-related hospitalizations.